NYSE:PJT
PJT Partners Inc.
A premier global boutique investment bank delivering high-value advisory and capital markets solutions across healthcare, technology, and energy industries.
Key Metrics
Investment Thesis
Bull Case
Investors should consider PJT as a high-quality growth play in the investment banking sector, supported by accelerating revenue growth and a return to double-digit net income expansion after recent volatility. The firm's dominant position in the healthcare advisory market provides a durable moat against larger bulge-bracket competitors who lack similar sector depth. Furthermore, the substantial cash balance of $538.9M offers flexibility for strategic investments or increased shareholder returns through dividends and buybacks while maintaining low leverage relative to total assets.
Bear Case
Potential downside arises from the inherent cyclicality of investment banking fees which could compress margins if deal volume declines in key sectors like technology or energy. The significant cash outflow from financing activities indicates aggressive capital return policies that may limit financial flexibility during periods of market stress or economic downturns. Additionally, the firm's exposure to non-controlling interests with $129.6M in net profit attributed to others suggests complex ownership structures that could complicate earnings quality assessments for traditional investors.
About PJT Partners Inc.
PJT Partners Inc. is a leading global investment bank specializing in strategic advisory, capital markets, and risk management services primarily serving the healthcare, technology, and energy sectors. The company leverages its deep industry expertise to execute complex transactions including M&A, restructuring, and equity offerings for private and public companies. With operations focused on New York, London, Singapore, and Hong Kong, PJT serves as a critical capital formation partner for mid-market clients seeking specialized financial solutions.
Analysis
Management Discussion
The company delivered robust financial performance in 2025 with revenue climbing to $1.71B from $1.49B the prior year, driven by a strong recovery in investment banking fees and capital markets activity. Net income surged to $309.7M compared to $238.5M previously, reflecting improved operational leverage and successful execution of high-value transactions across key verticals. Strong cash flow from operations of $526.3M highlights the firm's ability to generate liquidity despite significant financing outflows related to share repurchases totaling $195.2M.
Industry Overview
The global investment banking industry is characterized by high barriers to entry and intense competition among large universal banks and specialized boutiques for market share in M&A and capital raising. Success in this sector increasingly depends on deep vertical expertise rather than generalist capabilities, favoring firms that can navigate complex regulatory environments and provide niche industry insights. The current landscape favors agile intermediaries who can deliver tailored solutions to private companies seeking alternatives to public listings or distressed restructuring services.
Financial Statements
Income Statement
Balance Sheet
Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $1.03B | $1.15B | $1.49B | $1.71B |
| Cost of Revenue | $0 | $0 | $0 | $0 |
| Gross Profit | $1.03B | $1.15B | $1.49B | $1.71B |
| Operating Expenses | $824.0M | $975.6M | $1.22B | $1.37B |
| Operating Income | $201.5M | $177.6M | $270.6M | $342.9M |
| Stock-Based Comp | $165.5M | $178.5M | $209.2M | $234.3M |
| D&A | $15.5M | $14.0M | $12.8M | $13.3M |
| Depreciation | $9.0M | $9.1M | $7.7M | $7.8M |
| Amortization | $6.5M | $4.9M | $5.1M | $5.6M |
| Non-Operating Income | $0 | $0 | $0 | $0 |
| Pre-Tax Income | $201.5M | $177.6M | $270.6M | $342.9M |
| Income Tax | $36.7M | $31.9M | $32.1M | $33.2M |
| Continuing Ops | $164.8M | $145.7M | $238.5M | $309.7M |
| Discontinued Ops | $0 | $0 | $0 | $0 |
| Net Income | $164.8M | $145.7M | $238.5M | $309.7M |
| Minority Interest | $74.2M | $63.9M | $104.1M | $129.6M |
| Net to Common | $90.5M | $81.8M | $134.4M | $180.1M |
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Cash & Equivalents | $173.2M | $355.5M | $483.9M | $538.9M |
| PP&E (Net) | $30.7M | $25.9M | $22.1M | $61.0M |
| Goodwill | $172.7M | $172.7M | $191.6M | $191.6M |
| Operating Leases | $119.0M | $299.2M | $312.9M | $339.0M |
| Total Assets | $1.05B | $1.43B | $1.64B | $1.84B |
| Total Liabilities | $291.1M | $573.8M | $733.7M | $834.2M |
| Shareholders' Equity | $759.6M | $861.2M | $901.6M | $1.01B |
| Retained Earnings | $61.0M | $118.3M | $228.6M | $384.2M |
| AOCI | $-2.3M | $-467.0K | $-1.7M | $2.8M |
| Total L&E | $1.05B | $1.43B | $1.64B | $1.84B |
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net Income (CFO) | $164.8M | $145.7M | $238.5M | $309.7M |
| Non-Cash Adjustments | $36.3M | $254.0M | $141.4M | $116.7M |
| Working Capital Changes | $41.6M | $41.9M | $151.1M | $99.8M |
| Cash from Operations | $242.7M | $441.5M | $531.0M | $526.3M |
| Capital Expenditures | $3.4M | $3.9M | $3.3M | $45.9M |
| Cash from Investing | $-53.2M | $-34.3M | $8.1M | $-28.5M |
| Share Buybacks | $109.5M | $116.7M | $235.1M | $195.2M |
| Dividends Paid | $24.6M | $24.4M | $24.1M | $24.5M |
| Cash from Financing | $-210.0M | $-228.1M | $-408.7M | $-453.8M |
| FX Effect | $-6.7M | $3.2M | $-2.0M | $11.0M |
| Net Change in Cash | $-27.2M | $182.3M | $128.3M | $55.0M |
| Beginning Cash | $200.5M | $173.2M | $355.5M | $483.9M |
| Ending Cash | $173.2M | $355.5M | $483.9M | $538.9M |
Frequently Asked Questions
How does PJT Partners Inc. make money?
Core revenue streams include Investment Banking Advisory (M&A, restructuring, strategic advice), Capital Markets (equity/debt underwriting), Risk Management (insurance broking and analytics), and Wealth Management services for institutional and private client portfolios.
What are the main risks for PJT?
Client concentration risk within specific industries like healthcare could amplify losses if sector-specific M&A activity slows, potential for significant volatility in investment banking fee revenue due to the cyclical nature of deal markets, regulatory changes affecting broker-dealer operations or insurance broking practices, and reliance on key personnel given the firm's boutique structure where individual banker relationships drive deal origination.
What is PJT's competitive advantage?
PJT maintains a deep niche in the healthcare and life sciences sectors with unparalleled deal flow generation, possesses a highly concentrated team of industry-specialist bankers, and benefits from a diversified global footprint that mitigates single-market regulatory risks while capturing cross-border transaction opportunities.
Related Companies
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.